MLchartDataset catalogue

glymidine

Term · Oncology and biomedicine · MLC-T-ONC-013989

A sulfapyrimidine derivative,also known as glycodiazine, with antihyperglycemic activity. Like sulfonylureas, glymidine is able to lower blood glucose levels by increasing the release of insulin from pancreatic beta cells and increasing the sensitivity of peripheral tissues to insulin.

Table 1. Record
IdentifierMLC-T-ONC-013989
FieldOncology and biomedicine
Synonymsglycodiazine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013989",
  "term": "glymidine",
  "field": "Oncology and biomedicine",
  "definition": "A sulfapyrimidine derivative,also known as glycodiazine, with antihyperglycemic activity. Like sulfonylureas, glymidine is able to lower blood glucose levels by increasing the release of insulin from pancreatic beta cells and increasing the sensitivity of peripheral tissues to insulin.",
  "synonyms": [
    "glycodiazine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/glymidine/"
}

Record 8,083 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.